#COVID19 #clinicaltrials #treatment #biotechnology #vaccine #COVID
Smallpox, Vaccination, Vaccine, Immune system, Influenza vaccine, Influenza

2021 Biopharma Update on the Novel Coronavirus: January 26

On Jan 26, 2021
@biospace shared
2021 Biopharma Update on the Novel Coronavirus: January 26 #biospace #lifesciences #biotechnology #pharmaceuticals #clinicaltrials #COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine https://t.co/Ol87b8Wyws
Open

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 26, 2021.

www.biospace.com
On Jan 26, 2021
@biospace shared
2021 Biopharma Update on the Novel Coronavirus: January 26 #biospace #lifesciences #biotechnology #pharmaceuticals #clinicaltrials #COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine https://t.co/Ol87b8Wyws
Open

2021 Biopharma Update on the Novel Coronavirus: January 26

2021 Biopharma Update on the Novel Coronavirus: January 26

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 26, 2021.

2021 Biopharma Update on the Novel Coronavirus: January 12

2021 Biopharma Update on the Novel Coronavirus: January 12

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 12, 2021.

Yale doctor eyes rapid deployment approach to coronavirus vaccine

Yale doctor eyes rapid deployment approach to coronavirus vaccine

Getting a vaccine would be a good thing. Being able to make a lot of it, quickly, and get it to the masses would be even better.

Coronavirus vaccine developers make case to Congress they can win public's trust

Coronavirus vaccine developers make case to Congress they can win public's trust

While developing a safe and effective vaccine remains the chief challenge, lawmakers grilled pharma officials on how any successful shot would be fairly priced and distributed.

U.S. and Pfizer Are Negotiating Deal for More Vaccine Doses Next Year

U.S. and Pfizer Are Negotiating Deal for More Vaccine Doses Next Year

The Trump administration is discussing helping the drug maker get the raw materials it would need to produce tens of millions of extra doses of its Covid-19 vaccine in the spring.

How — and When — Can the Coronavirus Vaccine Become a Reality?

How — and When — Can the Coronavirus Vaccine Become a Reality?

It is likely we’ll eventually have a coronavirus vaccine — but perhaps not as quickly as some expect. From development, to clinical trials and distribution, ProPublica reporter Caroline ...

Fact Check: Q&A on Coronavirus Vaccines

Fact Check: Q&A on Coronavirus Vaccines

In the more than eight months since the novel coronavirus emerged and then spread around the world, scientists across the globe have made rapid progress on developing a COVID-19 vaccine. ...

SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn

SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn

Although the total number of cases of severe disease were small in these trials, substantially fewer severe cases were observed in vaccine recipients than placebo recipients (Table ...

The Covid-19 vaccines are a marvel of science. Here’s how we can make the best use of them

The Covid-19 vaccines are a marvel of science. Here’s how we can make the best use of them

It appears science may have found the Covid-19 pandemic’s off-ramp, but if we’re not careful, we could fail to take full advantage of it.

We Had the Vaccine the Whole Time

We Had the Vaccine the Whole Time

The silver bullet we’ve been waiting for took all of one weekend to design.

Episode 392 – The Future of Vaccines

Episode 392 – The Future of Vaccines

SOURCE: Health Expert: “Stop COVID Vax Experiments” Before the combined weight of the pharmaceutical manufacturers, global health bodies, governments and the corporate media combined to ...

Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines

Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines

Seasonal flu vaccine program will cover four seasonal viruses recommended by the World Health Organization (WHO) HIV vaccine program to accelerate human validation of novel vaccination ...

The coronavirus vaccine frontrunners have emerged. Here's where they stand

The coronavirus vaccine frontrunners have emerged. Here's where they stand

Fast progress by several companies has spurred hopes that a vaccine is coming soon. BioPharma Dive took a closer look at nine of those efforts, and how governments are jockeying to support ...

Pfizer could haul in $3.5B in 2021 from COVID-19 vaccine: analyst

Pfizer could haul in $3.5B in 2021 from COVID-19 vaccine: analyst

Pfizer is emerging as the clear frontrunner in the race to get a COVID-19 vaccine to market, but what will that be worth to investors? Analysts at SVB Leerink expect Pfizer and partner ...

9 Major Questions About mRNA Coronavirus Vaccines, Answered

9 Major Questions About mRNA Coronavirus Vaccines, Answered

From safety, to immunity, to mandates and beyond.

Coronavirus: What's happening in Canada and around the world on Thursday

Coronavirus: What's happening in Canada and around the world on Thursday

Germany's health minister said there are at least "10 hard weeks" ahead amid difficulties in getting large quantities of vaccines.

Covid-19 vaccination: What’s the evidence for extending the dosing interval?

Covid-19 vaccination: What’s the evidence for extending the dosing interval?

On 30 December the four UK chief medical officers announced that the second doses of the covid vaccines should be given towards the end of 12 weeks rather than in the previously recommended ...

Why Even Presidential Pressure Might Not Get More Vaccine to Market Faster

Why Even Presidential Pressure Might Not Get More Vaccine to Market Faster

Even invoking the widely heralded Defense Production Act to pressure drugmakers wouldn’t overcome vast obstacles.

Will a small, long-shot U.S. company end up producing the best coronavirus vaccine?

Will a small, long-shot U.S. company end up producing the best coronavirus vaccine?

Novavax vaccine shows “markedly stronger” responses in early human trials

Exclusive: U.S. plans massive coronavirus vaccine testing effort to meet year-end deadline

Exclusive: U.S. plans massive coronavirus vaccine testing effort to meet year-end deadline

The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine candidates in an effort to deliver a safe and ...